HQL Pharmaceuticals

Company Overview

Snapshot

Founded in January 2009, HQL Pharmaceuticals operates with 1–10 employees. The company has raised $2.5 million across one funding round. In 2014, HQL Pharmaceuticals formed a strategic alliance with Viva Biotech Ltd of Shanghai, China, to jointly provide drug discovery services.

Business overview

HQL Pharmaceuticals aims to transform drug discovery into a computationally driven, highly efficient process, focusing on generating diverse, high-quality drug candidates. The company's core technology is the ChemSpace Scanner (CSS) computational platform, which combines multiple drug design algorithms to screen vast chemical libraries against high-resolution drug models. HQL Pharmaceuticals serves the pharmaceutical and biotechnology industries, addressing challenges such as scaffold hopping, antagonizing protein-protein interactions, and transforming fragment hits into viable drug candidates.

Company Intelligence Q&A

What is HQL Pharmaceuticals' core technology?

HQL Pharmaceuticals utilizes its ChemSpace Scanner (CSS) computational platform, which integrates various drug design algorithms to screen extensive chemical libraries against high-resolution drug models, facilitating the discovery of high-quality drug candidates.

What strategic partnership did HQL Pharmaceuticals establish?

In 2014, HQL Pharmaceuticals entered into a strategic alliance with Viva Biotech Ltd of Shanghai, China, to collaboratively offer drug discovery services.

What challenges does HQL Pharmaceuticals' technology address in drug discovery?

The company's technology addresses challenges such as scaffold hopping, antagonizing protein-protein interactions, simultaneously targeting multiple proteins, and developing fragment hits into viable drug candidates.

What is the primary mission of HQL Pharmaceuticals?

HQL Pharmaceuticals' mission is to transform drug discovery into a computationally driven and highly efficient process, aiming to yield a large diversity of high-quality drug candidates.

What products does HQL Pharmaceuticals offer?

HQL Pharmaceuticals offers products including CSS and ChemSpace Scanner, which are integral to its computational drug discovery platform.